Zimbabwe has turned down a major US healthcare agreement valued at 367 million US dollars (272 million pounds) over five years due to Washington's insistence on sensitive information.
This move was revealed following a official document dated December was disclosed, revealing that President Emmerson Mnangagwa deemed the agreement was "lopsided".
A government spokesperson has since explained that the US was demanding access to biological samples for research and profit while refused to guarantee the resulting advantages from future medical innovations.
"We are forced to start the difficult and regrettable process of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the US had donated more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has urged further dialogue to secure a deal acceptable to all parties so the country's vital HIV programme can continue.
Wider Implications
This rejection comes after a comparable case in Kenya, where a high court halted a related health funding agreement following concerns were filed about the safety of Kenyans' medical information.
Since returning to office last year, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
USAID had overseen assistance for the American government, but Trump argued its spending was "inefficient" and his government was seeking direct bilateral agreements to boost transparency and accountability.
According to statements, 16 African countries have to date agreed to these new health pacts, representing more than $18.3bn in new funding.
Specifics of the Declined Agreement
This assistance for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We believe this partnership would have delivered extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently on HIV treatment via American-funded programmes," Tremont said.
However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".
"The proposal required Zimbabwe to surrender its genetic material and health information for a long time, with no corresponding assurance of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that shared data," Mangwana explained.
"Put simply, our country would provide the basic resources for scientific discovery without any certainty that the end products would be available to our population should a new health crisis arise."
National Interest and Global Health
Mangwana further pointed out that the American exit from the global health body and its push of bilateral deals were upending structures previously set up via the international health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system created to manage potential global health emergencies.
"This system is intended to guarantee that when a country contributes its data, the benefits – including medicines and cures – are distributed fairly, not monopolised solely by those with the funds to develop them."
The government's concerns over the US deal "must not be interpreted as opposition to America," he added.
"We are open to ongoing discussions with our American counterparts on how future collaboration could be structured in a manner that honours the sovereignty and dignity of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but urged that negotiations must proceed since a large portion of the country's HIV programmes relied on foreign aid.
"Where specific concerns arise, such as those involving data governance or agreement terms, these can often be addressed through technical clarification and mutually agreed protections," it commented.
The halted deal underscores the complex tensions between accepting much-needed foreign assistance and safeguarding a country's data in an increasingly interconnected world.